Future Trial – Peripheral Neuropathy
Open for enrollment
What is the Purpose of this STudy?
To determine which drug is the most effective in producing pain relief and improving quality of life in neuropathy patients and which drug has the fewest and which has the most side effects.
Who is Eligible to Participate?
Patients 30 or older with a diagnosis of neuropathy. No Diabetic Neuropathy. Patients will also have to meet all inclusion criteria which will be explained in greater detail by the study coordinator.
What is involved in this Study?
Patients will be randomized to 1 of 4 drug options (Nortiptyline, Mexiletine, Cymbalta or Lyrica). Patients will do monthly follow up appointments by phone to answer questions about the medication and their pain level.
How long is the Study?
This study will be approximately 6 months long.
For more information contact:
Lynette McKinney, MSCS, CRC, STudy Coordinator at 602-358-2271 or email@example.com